-
1
-
-
33846457870
-
Cancer statistics 2007
-
Jemal A, Siegel R, Ward E, Murray T, Xu J and Thun MJ: Cancer statistics 2007. CA Cancer J Clin 57: 43-66, 2007.
-
(2007)
CA Cancer J Clin
, vol.57
, pp. 43-66
-
-
Jemal, A.1
Siegel, R.2
Ward, E.3
Murray, T.4
Xu, J.5
Thun, M.J.6
-
2
-
-
34548232762
-
-
Verdecchia A, Francisci S, Brenner H, Gatta G, Micheli A, Mangone L, Kunkler I and EUROCARE-4 WorkingGroup: Recent cancer survival in Europe a 2000-02 period analysis of EUROCARE-4 data. Lancet Oncol 8: 784-796, 2007.
-
Verdecchia A, Francisci S, Brenner H, Gatta G, Micheli A, Mangone L, Kunkler I and EUROCARE-4 WorkingGroup: Recent cancer survival in Europe a 2000-02 period analysis of EUROCARE-4 data. Lancet Oncol 8: 784-796, 2007.
-
-
-
-
3
-
-
31644449749
-
Histologic criteria for diagnosing primary cutaneous malignant melanoma
-
Smoller BR: Histologic criteria for diagnosing primary cutaneous malignant melanoma. Mod Pathol 19: 34-40, 2006.
-
(2006)
Mod Pathol
, vol.19
, pp. 34-40
-
-
Smoller, B.R.1
-
4
-
-
31644448492
-
Prognosticators of melanoma, the melanoma report, and the sentinel lymph node
-
Crowson N, Magro CM and Mihm MC: Prognosticators of melanoma, the melanoma report, and the sentinel lymph node. Mod Pathol 19: S71-S87, 2006.
-
(2006)
Mod Pathol
, vol.19
-
-
Crowson, N.1
Magro, C.M.2
Mihm, M.C.3
-
5
-
-
0036207667
-
Inter-observer variation in the histopathological diagnosis of clinically suspicious pigmented skin lesions
-
Brochez L, Verhaeghe E, Grosshans E, Haneke E, Piérard G, Ruiter D and Naeyaert JM: Inter-observer variation in the histopathological diagnosis of clinically suspicious pigmented skin lesions. J Pathol 196: 459-466, 2002.
-
(2002)
J Pathol
, vol.196
, pp. 459-466
-
-
Brochez, L.1
Verhaeghe, E.2
Grosshans, E.3
Haneke, E.4
Piérard, G.5
Ruiter, D.6
Naeyaert, J.M.7
-
6
-
-
1542574206
-
Progression in cutaneous malignant melanoma is associated with distinct expression profiles. A tissue microarray-based study
-
Alonso SR, Ortiz P, Pollan M, Pérez-Gomez B, Sanchez L, Acuna MJ, Pajares R, Martinez-Tello FJ, Hortelano CM, Piris MA and Rodriguez-Peralto JL: Progression in cutaneous malignant melanoma is associated with distinct expression profiles. A tissue microarray-based study. Am J Pathol 164: 193-203, 2004.
-
(2004)
Am J Pathol
, vol.164
, pp. 193-203
-
-
Alonso, S.R.1
Ortiz, P.2
Pollan, M.3
Pérez-Gomez, B.4
Sanchez, L.5
Acuna, M.J.6
Pajares, R.7
Martinez-Tello, F.J.8
Hortelano, C.M.9
Piris, M.A.10
Rodriguez-Peralto, J.L.11
-
8
-
-
18144394273
-
Molecular diagnostics in melanoma
-
Carlson JA, Ross JS, Slominski A, Linette G, Mysliborski J, Hill J and Mihm M Jr: Molecular diagnostics in melanoma. J Am Acad Dermatol 52: 743-775, 2005.
-
(2005)
J Am Acad Dermatol
, vol.52
, pp. 743-775
-
-
Carlson, J.A.1
Ross, J.S.2
Slominski, A.3
Linette, G.4
Mysliborski, J.5
Hill, J.6
Mihm Jr, M.7
-
9
-
-
18344369398
-
Immunohistochemical detection of incipient melanoma micrometastases. Relationship with sentinel lymph node involvement
-
Claessens N, Piérard GE, Piérard-Franchimont C, Arrese JE and Quatresooz P: Immunohistochemical detection of incipient melanoma micrometastases. Relationship with sentinel lymph node involvement. Melanoma Res 15: 107-110, 2005.
-
(2005)
Melanoma Res
, vol.15
, pp. 107-110
-
-
Claessens, N.1
Piérard, G.E.2
Piérard-Franchimont, C.3
Arrese, J.E.4
Quatresooz, P.5
-
11
-
-
37349081263
-
Expression of immunohistochemical markers in primary and metastatic malignant melanoma: A comparative study in 70 patients using a tissue microarray technique
-
Plaza JA, Suster D and Perez-Montiel D: Expression of immunohistochemical markers in primary and metastatic malignant melanoma: a comparative study in 70 patients using a tissue microarray technique. Appl Immunohistochem Mol Morphol 15: 421-425, 2007.
-
(2007)
Appl Immunohistochem Mol Morphol
, vol.15
, pp. 421-425
-
-
Plaza, J.A.1
Suster, D.2
Perez-Montiel, D.3
-
13
-
-
48849098320
-
Highlighting the immunohistochemical profile of melanocytomas
-
Quatresooz P, Piérard-Franchimont C and Piérard GE: Highlighting the immunohistochemical profile of melanocytomas. Oncol Rep 19: 1367-1372, 2008.
-
(2008)
Oncol Rep
, vol.19
, pp. 1367-1372
-
-
Quatresooz, P.1
Piérard-Franchimont, C.2
Piérard, G.E.3
-
14
-
-
84868949910
-
Molecular histology on the diagnostic cutting edge between malignant melanomas and melanocytomas
-
and the Mosan Study Group of Pigmented Neoplasms:, In press
-
Quatresooz P, Piérard-Franchimont C, Rorive A, Nizet JL, Piérard GE and the Mosan Study Group of Pigmented Neoplasms: Molecular histology on the diagnostic cutting edge between malignant melanomas and melanocytomas. Exp Rev Dermatol (In press).
-
Exp Rev Dermatol
-
-
Quatresooz, P.1
Piérard-Franchimont, C.2
Rorive, A.3
Nizet, J.L.4
Piérard, G.E.5
-
15
-
-
38349165576
-
Identification of cells initiating human melanomas
-
Schatton T, Murphy GF, Frank NY, Yamaura K, Waaga-Gasser AM, Gasser M, Zhan Q, Jordan S, Duncan LM, Weishaupt C, Fuhlbrigge RC, Kupper TS, Sayegh MH and Frank MH: Identification of cells initiating human melanomas. Nature 451: 345-349, 2008.
-
(2008)
Nature
, vol.451
, pp. 345-349
-
-
Schatton, T.1
Murphy, G.F.2
Frank, N.Y.3
Yamaura, K.4
Waaga-Gasser, A.M.5
Gasser, M.6
Zhan, Q.7
Jordan, S.8
Duncan, L.M.9
Weishaupt, C.10
Fuhlbrigge, R.C.11
Kupper, T.S.12
Sayegh, M.H.13
Frank, M.H.14
-
16
-
-
41049114747
-
How to make a melanoma: What do we know of the primary clonal events? Pigment Cell
-
Bennett C: How to make a melanoma: what do we know of the primary clonal events? Pigment Cell Melanoma Res 21: 27-38, 2008.
-
(2008)
Melanoma Res
, vol.21
, pp. 27-38
-
-
Bennett, C.1
-
18
-
-
0025923920
-
Ki-67 immunostaining in melanocytic skin tumors. Correlation with histologic parameters
-
Soyer HP: Ki-67 immunostaining in melanocytic skin tumors. Correlation with histologic parameters. J Cutan Pathol 18: 264-272, 1991.
-
(1991)
J Cutan Pathol
, vol.18
, pp. 264-272
-
-
Soyer, H.P.1
-
19
-
-
0028239571
-
Karyometry of primary and metastatic malignant melanoma. A correlation with cell proliferation
-
Piérard-Franchimont C and Piérard GE: Karyometry of primary and metastatic malignant melanoma. A correlation with cell proliferation. Am J Dermatopathol 16: 247-252, 1994.
-
(1994)
Am J Dermatopathol
, vol.16
, pp. 247-252
-
-
Piérard-Franchimont, C.1
Piérard, G.E.2
-
20
-
-
0029775064
-
MIB-1 immunoreactivity correlates with metastatic dissemination in primary thick cutaneous melanoma
-
Boni R, Doguoglu A, Burg G, Muller B and Dummer R: MIB-1 immunoreactivity correlates with metastatic dissemination in primary thick cutaneous melanoma. J Am Acad Dermatol 35: 416-418, 1996.
-
(1996)
J Am Acad Dermatol
, vol.35
, pp. 416-418
-
-
Boni, R.1
Doguoglu, A.2
Burg, G.3
Muller, B.4
Dummer, R.5
-
21
-
-
0029801652
-
Factor XIIIa-positive dermal dendrocytes and proliferative activity of cutaneous cancers
-
Piérard-Franchimont C, Arrese JE, Nikkels AF, Al Saleh W, Delvenne P and Piérard GE: Factor XIIIa-positive dermal dendrocytes and proliferative activity of cutaneous cancers. Virchows Arch 429: 43-48, 1996.
-
(1996)
Virchows Arch
, vol.429
, pp. 43-48
-
-
Piérard-Franchimont, C.1
Arrese, J.E.2
Nikkels, A.F.3
Al Saleh, W.4
Delvenne, P.5
Piérard, G.E.6
-
22
-
-
0029783806
-
Nuclear morphometry, immuno-histochemical staining with Ki-67 antibody and mitotic index in the assessment of proliferative activity and prognosis of primary malignant melanomas of the skin
-
Talve LAI, Collan YUI and Ekfors TO: Nuclear morphometry, immuno-histochemical staining with Ki-67 antibody and mitotic index in the assessment of proliferative activity and prognosis of primary malignant melanomas of the skin. J Cutan Pathol 23: 335-343, 1996.
-
(1996)
J Cutan Pathol
, vol.23
, pp. 335-343
-
-
Talve, L.A.I.1
Collan, Y.U.I.2
Ekfors, T.O.3
-
23
-
-
0031891403
-
Prognostic significance of MIB-1 proliferative activity in thin melanomas and immunohistochemical analysis of MIB-1 proliferative activity in melanocytic tumors
-
Sparrow LE, English DR, Taran JM and Heenan PJ: Prognostic significance of MIB-1 proliferative activity in thin melanomas and immunohistochemical analysis of MIB-1 proliferative activity in melanocytic tumors. Am J Dermatopathol 20: 12-16, 1998.
-
(1998)
Am J Dermatopathol
, vol.20
, pp. 12-16
-
-
Sparrow, L.E.1
English, D.R.2
Taran, J.M.3
Heenan, P.J.4
-
24
-
-
0032973532
-
Prognostic evaluation of cutaneous malignant melanoma: A clinicopathologic and immunohistochemical study
-
Niezabitowski A, Czajecki K, Rys J, Kruczak A, Gruchala A, Wasilewska A, Lackowska B, Sokolowski A and Szklarski W: Prognostic evaluation of cutaneous malignant melanoma: a clinicopathologic and immunohistochemical study. J Surg Oncol 70: 150-160, 1999.
-
(1999)
J Surg Oncol
, vol.70
, pp. 150-160
-
-
Niezabitowski, A.1
Czajecki, K.2
Rys, J.3
Kruczak, A.4
Gruchala, A.5
Wasilewska, A.6
Lackowska, B.7
Sokolowski, A.8
Szklarski, W.9
-
25
-
-
0034103810
-
Loss of nuclear p16 protein expression correlates with increased tumor cell proliferation (Ki-67) and poor prognosis in patients with vertical growth phase melanoma
-
Straume O, Sviland L and Akslen LA: Loss of nuclear p16 protein expression correlates with increased tumor cell proliferation (Ki-67) and poor prognosis in patients with vertical growth phase melanoma. Clin Cancer Res 6: 1845-1853, 2000.
-
(2000)
Clin Cancer Res
, vol.6
, pp. 1845-1853
-
-
Straume, O.1
Sviland, L.2
Akslen, L.A.3
-
26
-
-
0035677699
-
High proliferative activity may predict early metastasis of thin melanomas
-
Frahm SO, Schubert C, Parwaresch R and Rudolp P: High proliferative activity may predict early metastasis of thin melanomas. Hum Pathol 32: 1376-1381, 2001.
-
(2001)
Hum Pathol
, vol.32
, pp. 1376-1381
-
-
Frahm, S.O.1
Schubert, C.2
Parwaresch, R.3
Rudolp, P.4
-
27
-
-
0344301855
-
Stochastic relationship between the growth fraction and vascularity of thin malignant melanomas
-
Piérard GE and Piérard-Franchimont C: Stochastic relationship between the growth fraction and vascularity of thin malignant melanomas. Eur J Cancer 33: 1888-1892, 1997.
-
(1997)
Eur J Cancer
, vol.33
, pp. 1888-1892
-
-
Piérard, G.E.1
Piérard-Franchimont, C.2
-
30
-
-
33845712739
-
Growth rate, early detection and prevention of melanoma. Melanoma epidemiology revisited and future challenges
-
Lipsker D: Growth rate, early detection and prevention of melanoma. Melanoma epidemiology revisited and future challenges. Arch Dermatol 142: 1638-1640, 2006.
-
(2006)
Arch Dermatol
, vol.142
, pp. 1638-1640
-
-
Lipsker, D.1
-
31
-
-
33745753404
-
Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature
-
Hoek KS, Schlegel NC, Brafford P, Sucker A, Ugurel S, Kumar R, Weber BL, Nathanson KL, Phillips DJ, Herlyn M, Schadendorf D and Dummer R: Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature. Pigment Cell Res 19: 290-302, 2006.
-
(2006)
Pigment Cell Res
, vol.19
, pp. 290-302
-
-
Hoek, K.S.1
Schlegel, N.C.2
Brafford, P.3
Sucker, A.4
Ugurel, S.5
Kumar, R.6
Weber, B.L.7
Nathanson, K.L.8
Phillips, D.J.9
Herlyn, M.10
Schadendorf, D.11
Dummer, R.12
-
32
-
-
35248899866
-
DNA microarray analyses of melanoma gene expression: A decade in the mines
-
Hoek KS: DNA microarray analyses of melanoma gene expression: a decade in the mines. Pigment Cell Res 20: 466-484, 2007.
-
(2007)
Pigment Cell Res
, vol.20
, pp. 466-484
-
-
Hoek, K.S.1
-
33
-
-
27844567142
-
Distinct sets of genetic alterations in melanoma
-
Curtin JA, Fridlyand J, Kageshita T, Patel HN, Busam KJ, Kutzner H, Cho KH, Aiba S, Bröcker EB, LeBoit PE, Pinkel D and Bastian BC: Distinct sets of genetic alterations in melanoma. N Engl J Med 353: 2135-2147, 2005.
-
(2005)
N Engl J Med
, vol.353
, pp. 2135-2147
-
-
Curtin, J.A.1
Fridlyand, J.2
Kageshita, T.3
Patel, H.N.4
Busam, K.J.5
Kutzner, H.6
Cho, K.H.7
Aiba, S.8
Bröcker, E.B.9
LeBoit, P.E.10
Pinkel, D.11
Bastian, B.C.12
-
34
-
-
34447515273
-
Genomic profiling of malignant melanoma using tiling-resolution array CGH
-
Jönsson G, Dahl C, Staaf J, Sandberg T, Bendahl PO, Ringner M, Guldberg P and Borg A: Genomic profiling of malignant melanoma using tiling-resolution array CGH. Oncogene 26: 4738-4748, 2007.
-
(2007)
Oncogene
, vol.26
, pp. 4738-4748
-
-
Jönsson, G.1
Dahl, C.2
Staaf, J.3
Sandberg, T.4
Bendahl, P.O.5
Ringner, M.6
Guldberg, P.7
Borg, A.8
-
36
-
-
34047258036
-
Genome-wide loss of heterozygosity and copy number analysis in melanoma using high-density single-nucleotide polymorphism arrays
-
Stark M and Hayward N: Genome-wide loss of heterozygosity and copy number analysis in melanoma using high-density single-nucleotide polymorphism arrays. Cancer Res 67: 2632-2642, 2007.
-
(2007)
Cancer Res
, vol.67
, pp. 2632-2642
-
-
Stark, M.1
Hayward, N.2
-
37
-
-
0035754080
-
To cycle or not to cycle: A critical decision in cancer
-
Malumbres M and Barbacid M: To cycle or not to cycle: a critical decision in cancer. Nat Rev Cancer 1: 222-231, 2001.
-
(2001)
Nat Rev Cancer
, vol.1
, pp. 222-231
-
-
Malumbres, M.1
Barbacid, M.2
-
38
-
-
0035092418
-
Expression of cyclins and cyclin dependent kinases in human benign and malignant melanocytic lesions
-
Georgieva J, Sinha P and Schadendorf D: Expression of cyclins and cyclin dependent kinases in human benign and malignant melanocytic lesions. J Clin Pathol 54: 229-235, 2001.
-
(2001)
J Clin Pathol
, vol.54
, pp. 229-235
-
-
Georgieva, J.1
Sinha, P.2
Schadendorf, D.3
-
39
-
-
0035668485
-
Cyclin A expression in superficial spreading malignant melanomas correlates with clinical outcome
-
Florenes VA, Maelandsmo GM, Faye R, Nesland JM and Holm R: Cyclin A expression in superficial spreading malignant melanomas correlates with clinical outcome. J Pathol 195: 530-536, 2001.
-
(2001)
J Pathol
, vol.195
, pp. 530-536
-
-
Florenes, V.A.1
Maelandsmo, G.M.2
Faye, R.3
Nesland, J.M.4
Holm, R.5
-
40
-
-
0033822962
-
Levels of cyclin D1 and D3 in malignant melanoma: Deregulated cyclin D3 expression is associated with poor clinical outcome in superficial melanoma
-
Florenes VA, Faye RS, Maelandsmo GM, Nesland JM and Holm R: Levels of cyclin D1 and D3 in malignant melanoma: deregulated cyclin D3 expression is associated with poor clinical outcome in superficial melanoma. Clin Cancer Res 6: 3614-3620, 2000.
-
(2000)
Clin Cancer Res
, vol.6
, pp. 3614-3620
-
-
Florenes, V.A.1
Faye, R.S.2
Maelandsmo, G.M.3
Nesland, J.M.4
Holm, R.5
-
41
-
-
0033394947
-
KIP1 and cyclin E in invasive primary malignant melanomas
-
KIP1 and cyclin E in invasive primary malignant melanomas. J Invest Dermatol 113: 1039-1046, 1999.
-
(1999)
J Invest Dermatol
, vol.113
, pp. 1039-1046
-
-
Bales, E.S.1
Deitrich, C.2
Bandyopadhyay, D.3
Schwahn, D.J.4
Xu, X.5
Didenko, V.6
Leiss, P.7
Cornad, N.8
Pereira-Smith, O.9
Orengo, I.10
Medarno, E.E.11
-
42
-
-
0030610586
-
NK4/CDKN2 gene in cutaneous malignant melanoma correlates with tumor cell proliferation and invasive stage
-
NK4/CDKN2 gene in cutaneous malignant melanoma correlates with tumor cell proliferation and invasive stage. Int J Cancer 74: 255-259, 1997.
-
(1997)
Int J Cancer
, vol.74
, pp. 255-259
-
-
Talve, L.1
Sauroja, I.2
Collan, Y.3
Punnonen, K.4
Ekfors, T.5
-
43
-
-
12244286059
-
Loss of p16 expression is associated with histological features of melanoma invasion
-
Pavey SJ, Cummings MC, Whiteman DC, Castellano M, Walsh MD, Gabrielli BG, Green A and Hayward NK: Loss of p16 expression is associated with histological features of melanoma invasion. Melanoma Res 12: 539-547, 2001.
-
(2001)
Melanoma Res
, vol.12
, pp. 539-547
-
-
Pavey, S.J.1
Cummings, M.C.2
Whiteman, D.C.3
Castellano, M.4
Walsh, M.D.5
Gabrielli, B.G.6
Green, A.7
Hayward, N.K.8
-
44
-
-
16644400331
-
Altered expression of cell cycle regulators cyclin D1, p14, p16, CDK4 and Rb in nodular melanomas
-
Bachmann IM, Straume O and Akslen LA: Altered expression of cell cycle regulators cyclin D1, p14, p16, CDK4 and Rb in nodular melanomas. Int J Oncol 25: 1559-1565, 2004.
-
(2004)
Int J Oncol
, vol.25
, pp. 1559-1565
-
-
Bachmann, I.M.1
Straume, O.2
Akslen, L.A.3
-
45
-
-
33846975038
-
Expression of p16, CD95L and helix pomatia agglutinin in relapsing and nonrelapsing very thin melanoma
-
Fearfield LA, Larkin JMG, Rowe A, A'Hern R, Fischer C, Francis N, MacKie R, McCann B, Gore ME and Bunker CB: Expression of p16, CD95L and helix pomatia agglutinin in relapsing and nonrelapsing very thin melanoma. Br J Dermatol 156: 440-447, 2007.
-
(2007)
Br J Dermatol
, vol.156
, pp. 440-447
-
-
Fearfield, L.A.1
Larkin, J.M.G.2
Rowe, A.3
A'Hern, R.4
Fischer, C.5
Francis, N.6
MacKie, R.7
McCann, B.8
Gore, M.E.9
Bunker, C.B.10
-
48
-
-
0030807729
-
Differential expression of growth arrest, DNA damage genes and tumour suppressor gene p53 in naevi and malignant melanomas
-
Korabiowska M, Betke H, Kellner S, Stachura J and Schauer A: Differential expression of growth arrest, DNA damage genes and tumour suppressor gene p53 in naevi and malignant melanomas. Anticancer Res 7: 3697-3700, 1997.
-
(1997)
Anticancer Res
, vol.7
, pp. 3697-3700
-
-
Korabiowska, M.1
Betke, H.2
Kellner, S.3
Stachura, J.4
Schauer, A.5
-
49
-
-
0033067733
-
WAF1/CIP1 expression in stage I cutaneous malignant melanoma: Its relationship with p53, cell proliferation and survival
-
WAF1/CIP1 expression in stage I cutaneous malignant melanoma: its relationship with p53, cell proliferation and survival. Br J Cancer 79: 895-902, 1999.
-
(1999)
Br J Cancer
, vol.79
, pp. 895-902
-
-
Karjalainen, J.M.1
Eskelinen, M.J.2
Kellokoski, J.K.3
Reinikainen, M.4
Alhava, E.M.5
Kosma, V.M.6
-
50
-
-
0032858974
-
Malignant melanoma arising from nevi, p53, p16, and bcl-2: Expression in benign versus malignant components
-
Rhadi JM: Malignant melanoma arising from nevi, p53, p16, and bcl-2: expression in benign versus malignant components. J Cutan Med Surg 3: 293-297, 1999.
-
(1999)
J Cutan Med Surg
, vol.3
, pp. 293-297
-
-
Rhadi, J.M.1
-
51
-
-
37549068850
-
Maspin and mutant p53 expression in malignant melanoma and carcinoma: Use of tissue microarray
-
Webber BA, Lawson D and Cohen C: Maspin and mutant p53 expression in malignant melanoma and carcinoma: use of tissue microarray. Appl Immunohistochem Mol Morphol 16: 19-23, 2008.
-
(2008)
Appl Immunohistochem Mol Morphol
, vol.16
, pp. 19-23
-
-
Webber, B.A.1
Lawson, D.2
Cohen, C.3
-
52
-
-
0038457811
-
Ki-67 and p53 expression in minimal deviation melanoma as compared with other nevomelanocytic lesions
-
Chorny JA, Barr RJ, Kyshtoobayeva A, Jakowatz J and Reed RJ: Ki-67 and p53 expression in minimal deviation melanoma as compared with other nevomelanocytic lesions. Mod Pathol 16: 525-529, 2003.
-
(2003)
Mod Pathol
, vol.16
, pp. 525-529
-
-
Chorny, J.A.1
Barr, R.J.2
Kyshtoobayeva, A.3
Jakowatz, J.4
Reed, R.J.5
-
53
-
-
0034934743
-
Immunohistochemical study of 49 cutaneous melanomas: P53, PCNA, Bcl-2 expression and multidrug resistance
-
Loggini B, Rinaldi I Pingitore R, Cristofani R, Catagna M and Barachini P: Immunohistochemical study of 49 cutaneous melanomas: p53, PCNA, Bcl-2 expression and multidrug resistance. Tumori 87: 179-186, 2001.
-
(2001)
Tumori
, vol.87
, pp. 179-186
-
-
Loggini, B.1
Rinaldi, I.2
Pingitore, R.3
Cristofani, R.4
Catagna, M.5
Barachini, P.6
-
54
-
-
0035887146
-
HDM2 protein over-expression, but not gene amplification, is related to tumorigenesis of cutaneous melanoma
-
Polsky D, Bastian BC, Hazan C, Melzer K, Pack J, Houghton A, Busam K, Cordon-Cardo C and Osman I: HDM2 protein over-expression, but not gene amplification, is related to tumorigenesis of cutaneous melanoma. Cancer Res 61: 7642-7646, 2001.
-
(2001)
Cancer Res
, vol.61
, pp. 7642-7646
-
-
Polsky, D.1
Bastian, B.C.2
Hazan, C.3
Melzer, K.4
Pack, J.5
Houghton, A.6
Busam, K.7
Cordon-Cardo, C.8
Osman, I.9
-
55
-
-
0037021660
-
HDM2 protein overexpression and prognosis in primary malignant melanoma
-
Polsky D, Melzer K, Hazan C, Panageas KS, Busam K, Drobnjak M, Kamino H, Spira JG, Kopf AW, Houghton A, Cordon-Cardo C and Osman I: HDM2 protein overexpression and prognosis in primary malignant melanoma. J Natl Cancer Inst 94: 1803-1806, 2002.
-
(2002)
J Natl Cancer Inst
, vol.94
, pp. 1803-1806
-
-
Polsky, D.1
Melzer, K.2
Hazan, C.3
Panageas, K.S.4
Busam, K.5
Drobnjak, M.6
Kamino, H.7
Spira, J.G.8
Kopf, A.W.9
Houghton, A.10
Cordon-Cardo, C.11
Osman, I.12
-
56
-
-
0037032817
-
Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases
-
Johnson G and Lapadat R: Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298: 1911-1912, 2001.
-
(2001)
Science
, vol.298
, pp. 1911-1912
-
-
Johnson, G.1
Lapadat, R.2
-
57
-
-
34547913062
-
p38 MAPK inhibitors in dermatology
-
Ihn H: p38 MAPK inhibitors in dermatology. Expert Rev Dermatol 2: 403-407, 2007.
-
(2007)
Expert Rev Dermatol
, vol.2
, pp. 403-407
-
-
Ihn, H.1
-
58
-
-
16844376315
-
Oncogenic ras in tumour progression and metastasis
-
Giehl K: Oncogenic ras in tumour progression and metastasis. Biol Chem 386: 193-205, 2005.
-
(2005)
Biol Chem
, vol.386
, pp. 193-205
-
-
Giehl, K.1
-
59
-
-
1242340431
-
-
Campbell PM and Der CJ: Oncogenic ras and its role in tumor cell invasion and metastasis. Semin Cancer Biol 14: 105-114, 2004.
-
Campbell PM and Der CJ: Oncogenic ras and its role in tumor cell invasion and metastasis. Semin Cancer Biol 14: 105-114, 2004.
-
-
-
-
60
-
-
18444374405
-
-
Davies H, Gibnell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W, Davis N, Dicks E, Ewing R, Floyd Y, Gray K, Hall S, Hawes R, Hughes J, Kosmidou V, Menzies A, Mould C, Parker A, Stevens C, Watt S, Hooper S, Wilson R, Jayatilake H, Gusterson BA, Cooper C, Shipley J, Hargrave D, Pritchard-Jones K, Maitland N, Chenevix-Trench G, Riggins GJ, Bigner DD, Palmieri G, Cossu A, Flanagan A, Nicholson A, Ho JW, Leung SY, Yuen ST, Weber GL, Seigler HF, Darrow TL, Paterson H, Marais R, Marshall CJ, Wooster R, Stratton MR and Futreal PA: Mutations of the BRAF gene in human cancer. Nature 417: 949-954, 2002.
-
Davies H, Gibnell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W, Davis N, Dicks E, Ewing R, Floyd Y, Gray K, Hall S, Hawes R, Hughes J, Kosmidou V, Menzies A, Mould C, Parker A, Stevens C, Watt S, Hooper S, Wilson R, Jayatilake H, Gusterson BA, Cooper C, Shipley J, Hargrave D, Pritchard-Jones K, Maitland N, Chenevix-Trench G, Riggins GJ, Bigner DD, Palmieri G, Cossu A, Flanagan A, Nicholson A, Ho JW, Leung SY, Yuen ST, Weber GL, Seigler HF, Darrow TL, Paterson H, Marais R, Marshall CJ, Wooster R, Stratton MR and Futreal PA: Mutations of the BRAF gene in human cancer. Nature 417: 949-954, 2002.
-
-
-
-
61
-
-
27244457769
-
RAF, a strategic target for therapeutic development against cancer
-
Beeram M, Patnaik A and Rowinsky EK: RAF, a strategic target for therapeutic development against cancer. J Clin Oncol 23: 6771-6790, 2005.
-
(2005)
J Clin Oncol
, vol.23
, pp. 6771-6790
-
-
Beeram, M.1
Patnaik, A.2
Rowinsky, E.K.3
-
62
-
-
34248630805
-
Confirmation of a BRAF mutation-associated gene expression signature in melanoma
-
Johansson P, Pavey S and Hayward N: Confirmation of a BRAF mutation-associated gene expression signature in melanoma. Pigment Cell Res 20: 216-221, 2007.
-
(2007)
Pigment Cell Res
, vol.20
, pp. 216-221
-
-
Johansson, P.1
Pavey, S.2
Hayward, N.3
-
63
-
-
0028152333
-
MAP kinase kinase kinase, MAP kinase kinase and MAP kinase
-
Marshall CJ: MAP kinase kinase kinase, MAP kinase kinase and MAP kinase. Curr Opin Genet Dev 4: 82-89, 1994.
-
(1994)
Curr Opin Genet Dev
, vol.4
, pp. 82-89
-
-
Marshall, C.J.1
-
64
-
-
0343492260
-
Structure and biological activity of v-raf, a unique oncogene transduced by a retrovirus
-
Rapp UR, Goldsborough MD, Mark GE, Bonner TI, Groffen J, Reynolds FH and Stephenson JR: Structure and biological activity of v-raf, a unique oncogene transduced by a retrovirus. Proc Natl Acad Sci USA 80: 4218-4222, 1983.
-
(1983)
Proc Natl Acad Sci USA
, vol.80
, pp. 4218-4222
-
-
Rapp, U.R.1
Goldsborough, M.D.2
Mark, G.E.3
Bonner, T.I.4
Groffen, J.5
Reynolds, F.H.6
Stephenson, J.R.7
-
65
-
-
0037228055
-
High frequency of BRAF mutations in nevi
-
Pollock PM, Harper UL, Hansen KS, Yudt LM, Sark M, Robbins CM, Moses TY, Hostetter G, Wagner U, Kakareka J, Salem G, Phoida T, Heenan P, Duray P, Kallioniemi O, Hayward NK, Trent JM and Meltzer PS: High frequency of BRAF mutations in nevi. Nat Genet 33: 19-20, 2003.
-
(2003)
Nat Genet
, vol.33
, pp. 19-20
-
-
Pollock, P.M.1
Harper, U.L.2
Hansen, K.S.3
Yudt, L.M.4
Sark, M.5
Robbins, C.M.6
Moses, T.Y.7
Hostetter, G.8
Wagner, U.9
Kakareka, J.10
Salem, G.11
Phoida, T.12
Heenan, P.13
Duray, P.14
Kallioniemi, O.15
Hayward, N.K.16
Trent, J.M.17
Meltzer, P.S.18
-
66
-
-
33947230256
-
Distinct clinical and pathological features are associated with BRAF mutation in primary melanoma
-
Liu W, Kelly JW, Trivett M, Murray WK, Dowling JP, Wolfe R, Mason G, Magee J, Angel C, Dobrovic A and McArthur GA: Distinct clinical and pathological features are associated with BRAF mutation in primary melanoma. J Invest Dermatol 127: 900-905, 2007.
-
(2007)
J Invest Dermatol
, vol.127
, pp. 900-905
-
-
Liu, W.1
Kelly, J.W.2
Trivett, M.3
Murray, W.K.4
Dowling, J.P.5
Wolfe, R.6
Mason, G.7
Magee, J.8
Angel, C.9
Dobrovic, A.10
McArthur, G.A.11
-
67
-
-
0036654443
-
A genome-based strategy uncovers frequent BRAF mutations in melanoma
-
Pollock PM and Meltzer PS: A genome-based strategy uncovers frequent BRAF mutations in melanoma. Cancer Cell 2: 5-7, 2002.
-
(2002)
Cancer Cell
, vol.2
, pp. 5-7
-
-
Pollock, P.M.1
Meltzer, P.S.2
-
68
-
-
0036894746
-
BRAF and RAS mutations in human lung cancer and melanoma
-
Brose MS, Volpe P, Feldman M, Kumar M, Rishi I, Gerrero R, Einhorn E, Herlyn M, Minna J, Nicholson A, Roth JA, Albelda SM, Davies H, Cox C, Brignell G, Stephens P, Futreal PA, Wooster R, Stratton MR and Weber BL: BRAF and RAS mutations in human lung cancer and melanoma. Cancer Res 62: 6997-7000, 2002.
-
(2002)
Cancer Res
, vol.62
, pp. 6997-7000
-
-
Brose, M.S.1
Volpe, P.2
Feldman, M.3
Kumar, M.4
Rishi, I.5
Gerrero, R.6
Einhorn, E.7
Herlyn, M.8
Minna, J.9
Nicholson, A.10
Roth, J.A.11
Albelda, S.M.12
Davies, H.13
Cox, C.14
Brignell, G.15
Stephens, P.16
Futreal, P.A.17
Wooster, R.18
Stratton, M.R.19
Weber, B.L.20
more..
-
69
-
-
34547951896
-
Mechanism of UV-related carcinogenesis and its contribution to nevi/ melanoma. Expert Rev
-
Brozyna A, Zbytek B, Granese J, Carlson JA, Ross J and Slominski A: Mechanism of UV-related carcinogenesis and its contribution to nevi/ melanoma. Expert Rev Dermatol 2: 451-469, 2007.
-
(2007)
Dermatol
, vol.2
, pp. 451-469
-
-
Brozyna, A.1
Zbytek, B.2
Granese, J.3
Carlson, J.A.4
Ross, J.5
Slominski, A.6
-
70
-
-
0347504782
-
Cutaneous melanomas associated with nevi
-
Bevona C, Goggins W, Quinn T, Fullerton J and Tsao H: Cutaneous melanomas associated with nevi. Arch Dermatol 139: 1620-1624, 2003.
-
(2003)
Arch Dermatol
, vol.139
, pp. 1620-1624
-
-
Bevona, C.1
Goggins, W.2
Quinn, T.3
Fullerton, J.4
Tsao, H.5
-
71
-
-
10744222648
-
Mutations of the BRAF gene in benign and malignant melanocytic lesions
-
Yazdi AS, Palmedo G, Flaig MJ, Puchta U, Reckwerth A, Rütten A, Mentzel T, Hügel H, Hantschke M, Schmid-Wendtner MH, Kutzner H and Sander CA: Mutations of the BRAF gene in benign and malignant melanocytic lesions. J Invest Dermatol 121: 1160-1162, 2003.
-
(2003)
J Invest Dermatol
, vol.121
, pp. 1160-1162
-
-
Yazdi, A.S.1
Palmedo, G.2
Flaig, M.J.3
Puchta, U.4
Reckwerth, A.5
Rütten, A.6
Mentzel, T.7
Hügel, H.8
Hantschke, M.9
Schmid-Wendtner, M.H.10
Kutzner, H.11
Sander, C.A.12
-
72
-
-
0346728596
-
Determinants of BRAF mutations in primary melanomas
-
Maldonado JL, Fridlyand J, Patel H, Jain AN, Busam K, Kageshita T, Ono T, Albertson DG, Pinkel D and Bastian BC: Determinants of BRAF mutations in primary melanomas. J Natl Cancer Inst 95: 1878-1890, 2003.
-
(2003)
J Natl Cancer Inst
, vol.95
, pp. 1878-1890
-
-
Maldonado, J.L.1
Fridlyand, J.2
Patel, H.3
Jain, A.N.4
Busam, K.5
Kageshita, T.6
Ono, T.7
Albertson, D.G.8
Pinkel, D.9
Bastian, B.C.10
-
73
-
-
2942607408
-
Constitutive activation of the ras-raf signalling pathway in metastatic melanoma is associated with poor prognosis
-
Houben R, Becker JC, Kappel A, Terheyden P, Bröcker EB, Goetz R and Rapp UR: Constitutive activation of the ras-raf signalling pathway in metastatic melanoma is associated with poor prognosis. J Carcinog 3: 6, 2004.
-
(2004)
J Carcinog
, vol.3
, pp. 6
-
-
Houben, R.1
Becker, J.C.2
Kappel, A.3
Terheyden, P.4
Bröcker, E.B.5
Goetz, R.6
Rapp, U.R.7
-
74
-
-
27144527955
-
Prevalence of exon 15 BRAF mutations in primary melanoma of the superficial spreading, nodular, acral and lentigo maligna subtypes
-
Lang J and MacKie RM: Prevalence of exon 15 BRAF mutations in primary melanoma of the superficial spreading, nodular, acral and lentigo maligna subtypes. J Invest Dermatol 125: 575-579, 2005.
-
(2005)
J Invest Dermatol
, vol.125
, pp. 575-579
-
-
Lang, J.1
MacKie, R.M.2
-
75
-
-
2542481723
-
Exon 15 BRAF mutations are uncommon in melanomas arising in non sun-exposed sites
-
Cohen Y, Rosenbaum E, Begum S, Goldenberg D, Esche C, Lavie O, Sidransky D and Westra WH: Exon 15 BRAF mutations are uncommon in melanomas arising in non sun-exposed sites. Clin Cancer Res 15: 3444-3447, 2004.
-
(2004)
Clin Cancer Res
, vol.15
, pp. 3444-3447
-
-
Cohen, Y.1
Rosenbaum, E.2
Begum, S.3
Goldenberg, D.4
Esche, C.5
Lavie, O.6
Sidransky, D.7
Westra, W.H.8
-
76
-
-
33746589029
-
MC1R germline variants confer risk for BRAF-mutant melanoma
-
Landi MT, Bauer J, Pfeiffer RM, Elder DE, Hulley B, Minghetti P, Calista D, Kantesky PA, Pinkel D and Bastian BC: MC1R germline variants confer risk for BRAF-mutant melanoma. Science 313: 521-522, 2006.
-
(2006)
Science
, vol.313
, pp. 521-522
-
-
Landi, M.T.1
Bauer, J.2
Pfeiffer, R.M.3
Elder, D.E.4
Hulley, B.5
Minghetti, P.6
Calista, D.7
Kantesky, P.A.8
Pinkel, D.9
Bastian, B.C.10
-
77
-
-
33646705144
-
Melanoma genetics: A review of genetic factors and clinical phenotypes in familial melanoma
-
Pho L, Grossman D and Leachman SA: Melanoma genetics: a review of genetic factors and clinical phenotypes in familial melanoma. Curr Opin Oncol 18: 173-179, 2006.
-
(2006)
Curr Opin Oncol
, vol.18
, pp. 173-179
-
-
Pho, L.1
Grossman, D.2
Leachman, S.A.3
-
78
-
-
33646685680
-
Overexpression of phosphorylated-STAT3 and phosphorylated-ERK protein in dermatofibrosarcoma protuberans
-
Lin N, Urabe K, Moroi Y, Uchi H, Nakahara T, Dainichi T, Kokuba H, Tu Y and Furue M: Overexpression of phosphorylated-STAT3 and phosphorylated-ERK protein in dermatofibrosarcoma protuberans. Eur J Dermatol 16: 262-265, 2006.
-
(2006)
Eur J Dermatol
, vol.16
, pp. 262-265
-
-
Lin, N.1
Urabe, K.2
Moroi, Y.3
Uchi, H.4
Nakahara, T.5
Dainichi, T.6
Kokuba, H.7
Tu, Y.8
Furue, M.9
-
79
-
-
9144267697
-
Prognostic significance of phosphorylated P38 mitogen-activated protein kinase and HER-2 expression in lymph node-positive breast carcinoma
-
Esteva FJ, Sahin AA, Smith TL, Yang Y, Pusztai L, Nahta R, Buchholz TA, Buzdar AU, Hortobagyi GN and Bacus SS: Prognostic significance of phosphorylated P38 mitogen-activated protein kinase and HER-2 expression in lymph node-positive breast carcinoma. Cancer 100: 499-506, 2004.
-
(2004)
Cancer
, vol.100
, pp. 499-506
-
-
Esteva, F.J.1
Sahin, A.A.2
Smith, T.L.3
Yang, Y.4
Pusztai, L.5
Nahta, R.6
Buchholz, T.A.7
Buzdar, A.U.8
Hortobagyi, G.N.9
Bacus, S.S.10
-
80
-
-
27144557960
-
A tumorigenic subpopulation with stem cell properties in melanomas
-
Fang D, Nguyen TK, Leishear K, Finko R, Kulp AN, Hotz S, van Belle PA, Xu X, Elder DE and Herlyn M: A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res 65: 9328-9337, 2005.
-
(2005)
Cancer Res
, vol.65
, pp. 9328-9337
-
-
Fang, D.1
Nguyen, T.K.2
Leishear, K.3
Finko, R.4
Kulp, A.N.5
Hotz, S.6
van Belle, P.A.7
Xu, X.8
Elder, D.E.9
Herlyn, M.10
-
81
-
-
33644787015
-
Melanoma, a tumor based on a mutant stem cell?
-
Grichnik JM, Burch JA, Schulteis RD, Shan S, Liu J, Darrow TL, Vervaert CE and Seigler HF: Melanoma, a tumor based on a mutant stem cell? J Invest Dermatol 126: 142-153, 2006.
-
(2006)
J Invest Dermatol
, vol.126
, pp. 142-153
-
-
Grichnik, J.M.1
Burch, J.A.2
Schulteis, R.D.3
Shan, S.4
Liu, J.5
Darrow, T.L.6
Vervaert, C.E.7
Seigler, H.F.8
-
82
-
-
38449090512
-
Stem cells of the melanocyte lineage
-
Buac K and Pavan WJ: Stem cells of the melanocyte lineage. Cancer Biomark 3: 203-209, 2007.
-
(2007)
Cancer Biomark
, vol.3
, pp. 203-209
-
-
Buac, K.1
Pavan, W.J.2
-
83
-
-
33845702260
-
Increased expression of stem cell markers in malignant melanoma
-
Klein WM, Wu BP, Zhao S, Wu H, Klein-Szanto AJ and Tahan SR: Increased expression of stem cell markers in malignant melanoma. Mod Pathol 20: 102-107, 2007.
-
(2007)
Mod Pathol
, vol.20
, pp. 102-107
-
-
Klein, W.M.1
Wu, B.P.2
Zhao, S.3
Wu, H.4
Klein-Szanto, A.J.5
Tahan, S.R.6
-
84
-
-
41049111969
-
Cancer stem cells and human malignant melanoma
-
Schatton T and Franck MH: Cancer stem cells and human malignant melanoma. Pigment Cell Melanoma Res 21: 39-55, 2007.
-
(2007)
Pigment Cell Melanoma Res
, vol.21
, pp. 39-55
-
-
Schatton, T.1
Franck, M.H.2
-
85
-
-
58049201990
-
The stem cell-associated antigen CD133 (Prominin-1) is a molecular therapeutic target for metastatic melanoma
-
Rappa G, Fodstad O and Lorico A: The stem cell-associated antigen CD133 (Prominin-1) is a molecular therapeutic target for metastatic melanoma. Stem Cells 26: 2008-3017, 2008.
-
(2008)
Stem Cells
, vol.26
, pp. 2008-3017
-
-
Rappa, G.1
Fodstad, O.2
Lorico, A.3
-
86
-
-
0037372013
-
Apoptosis and melanoma: Molecular mechanisms
-
Hussein M, Haemel A and Wood ES: Apoptosis and melanoma: molecular mechanisms. J Pathol 199: 275-288, 2003.
-
(2003)
J Pathol
, vol.199
, pp. 275-288
-
-
Hussein, M.1
Haemel, A.2
Wood, E.S.3
-
87
-
-
0033014996
-
Apoptosis, Fas and Fas-ligand expression in melanocytic tumors
-
Sprecher E, Bergman R, Meilick A, Kerner H, Manov L, Reiter I, Shafer Y, Maor G and Friedman-Birnbaum R: Apoptosis, Fas and Fas-ligand expression in melanocytic tumors. J Cutan Pathol 26: 72-77, 1999.
-
(1999)
J Cutan Pathol
, vol.26
, pp. 72-77
-
-
Sprecher, E.1
Bergman, R.2
Meilick, A.3
Kerner, H.4
Manov, L.5
Reiter, I.6
Shafer, Y.7
Maor, G.8
Friedman-Birnbaum, R.9
|